AI Tool Comparison
Comparing as AI Remote Patient MonitoringHinge Health vs Current Health
Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.

Hinge Health
VS

Current Health
Verdict by Category
Detailed category analysis is not available for this comparison.
Detailed Comparison
Feature
Hinge Health
Current Health
Pricing
CustomHinge Health is a B2B platform available exclusively through employer benefits contracts. It is not sold direct-to-consumer.
Pricing is primarily engagement-based \u2014 employers pay only when members actively use the program, aligning costs with actual program utilization. Approximately 80% of contracted lives are on the engagement-based model. A per-member-per-month (PMPM) model is also available.
Employer ROI is demonstrated through surgical avoidance, reduced specialist visits, and decreased musculoskeletal healthcare costs. Contact Hinge Health through hingehealth.com for employer pricing and implementation details.
EnterpriseCurrent Health is an enterprise-only platform with no public pricing. All deployments are custom contracts negotiated directly with health systems, payers, and home health agencies.
Pricing is based on patient volume, care program type (Hospital@Home, chronic care management, post-acute monitoring), integration requirements, and the level of Clinical Command Center support required.
Contact Current Health through currenthealth.com to request a demo and enterprise pricing discussion.
Categories
AI Healthcare ToolsAI Productivity Tools
AI Healthcare ToolsAI Productivity Tools
Summary
Digital MSK clinic with TrueMotion AI and Enso wearable — surgical avoidance and physical therapy for employers
Enterprise care-at-home platform — FDA-cleared wearable monitoring, telehealth, and clinical command center
Hinge Health Pros & Cons
Pros
- NYSE: HNGE, $5.29B market cap, $732M projected 2026 revenue — strongest financial position in digital MSK
- TrueMotion AI motion tracking enables real-time PT form feedback without in-person visits
- FDA-cleared Enso wearable provides medication-free pain relief via electrical nerve stimulation
- 85% of HingeSelect members choose conservative digital PT over surgery — proven surgical avoidance outcomes
- Engagement-based pricing aligns employer costs with actual member usage
- Epic EHR integration connects MSK care data with existing health system records
- Expanded to Migraine Care (2026) — platform extending beyond MSK into broader condition management
Cons
- B2B employer-only model — not directly accessible to individuals without employer coverage
- Focused exclusively on MSK conditions — not a general-purpose virtual care platform
- Engagement-based pricing can create budget uncertainty for employer clients
- Relatively recent IPO (May 2025) — limited track record as a public company
- Geographic focus primarily US — limited international availability
Current Health Pros & Cons
Pros
- FDA-cleared wearable delivers ICU-level vital sign accuracy at home — highest clinical standard in consumer RPM
- Acquired by Best Buy (2021) — enterprise-scale logistics, retail distribution, and commercial backing
- Trusted by Mount Sinai, Geisinger, Mayo Clinic, UK NHS, and AstraZeneca — proven at top-tier health systems
- All-in-one platform: RPM + telehealth + patient engagement + command center in single solution
- 24/7 Clinical Command Center reduces provider burden — offloads monitoring operations from health system staff
- Customizable clinical algorithms per patient — reduces false alarms and focuses alerts on clinically meaningful signals
- Revenues grew 3,000% YoY in 2020 — proven market demand and real-world scalability
Cons
- Enterprise-only platform — not available for individual clinicians or small practices
- Requires Best Buy Health partnership for full deployment — limits flexibility for some health systems
- No public pricing — evaluation requires direct sales engagement
- Device-dependent model — requires wearable distribution logistics and patient onboarding
- Primarily focused on US and UK markets
- Competition from Biofourmis, Teladoc, and other RPM platforms with similar hospital-at-home capabilities